Compliance, efficacy and quality of life;Observance, efficacité et qualité de vie

Therapie

Volumn 57, Issue 4, 2002, Pages 366-378

  Bergmann, J F ^a   Dohin, E ^b   Juillet, Y ^c  

^a Fondation Ophtalmologique Rothschild   (France)

^b Laboratoire MSD   (France)

^c SANOFI   (France)

Author keywords

Clinical trials; Compliance; Quality of life; Therapeutics

Indexed keywords

CONFERENCE PAPER; HEALTH CARE; HUMAN; ILLNESS BEHAVIOR; MOTIVATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL ANALYSIS; TRAINING; VALIDATION PROCESS;

DRUG THERAPY; HABITS; MODELS, STATISTICAL; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 0036660686     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Cramer JA, Spilker B. Patients compliance in medical practice and medical trials. Raven Press, New York, 416 pages, 1991
2. Dahan R, Dahan A, Cadranel J, et al. La compliance: mesure de l'adhérence au traitement et au suivi thérapeutique. Thérapie 1985; 40: 17-23
3. Postel-Vinay N, Ménard J. Observance en pratique médicale courante. Encycl Med Chir (Elsevier, Paris), Encyclopédie Pratique de Médecine, 1-0030, 1998, 4 p
4. Meichelbaum D, Turk DC. Factors affecting adherence. In: Facilitating treatment adherence. Plenum Press, New York & London, 1987: 41-68
5. Becker MH, Maiman LA. Sociobehavioural determinants of compliance with health care and medical care recommendations. Med Care 1975; 13: 10-24
6. O'Connell KA, Cook MR, Gerkovich MM, et al. Reversal theory and smoking: A state-based approach to ex-smokers' highly tempting situations. J Consult Clin Psychol 1990; 58: 489-494
7. Apter MJ. The experience of motivation. The theory of psychological reversals. London and New York: Academic Press, 1982
8. Wallston BS, Wallston KA. Locus of control and health: a review of the literature. Health education monographs, Spring 1978: 107-117
9. Vincent P. Factors influencing patient non-compliance: a theoretical approach. Nursing Res 1971; 20: 509-516
10. Blackwell B. Ed. Treatment compliance and the therapeutic alliance. Harwood Academic Publishers, Amsterdam 1997: 2-13
11. Bergmann JF. Observance. In: Caulin Ch, Chastang CI, Dahan R, eds Masson. Méthodologie de l'évaluation thérapeutique, 1993: 42-50
12. Martin KA, Bowen DJ, Dunbar-Jacob J, et al. Who will adhere? Key issues in the study and prediction of adherence in randomized controlled trials. Control Clin Trials 2000; 21: 195S-199S
13. Note for guidance on good clinical practice 1997, ICH Topic E6
14. ICH-E9 Statistical principles for clinical trials, 1998
15. ICH-E6 Clinical trial protocol and protocol amendments, 1997
16. ICH-E8 General considerations for clinical trials, 1995
17. ICH-E3 Structure and content of clinical study reports. 1995
18. Tashkin DP. Multiple dose regimens - Impact on compliance. Chest 1995; 107: 1765-1825
19. Vander Stichele R. Measurement of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharmacol 1991; 41: 27-35
20. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993; 153: 1863-1868
21. Boudes P. Drug compliance in therapeutic trials: a review. Control Clin Trials 1998; 19: 257-268
22. Chassany O, Pierre Sagnier F, Marquis P. et al. Patient-reported outcomes: the example of health-related quality of life - a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Info J 2002; 36: 209-238
23. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000; 343: 332-336
24. Borras JM, Sanchez-Hernandez A, Navarro M, et al. Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial. BMJ 2001; 322: 1-5
25. Leroyer C, Lebrun T, Proust A, et al. Knowledge, self-management, compliance and quality of life in asthma: a cross-sectional study of the French version of the Asthma Quality of Life Questionnaire. Qual Life Res 1998; 7: 267-272
26. Bultman DC, Svarstad BL. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Education and Counseling 2000; 40: 173-185
27. Newell SA, Bowman JA. Cockburn JD. A critical review of interventions to increase compliance with medication-taking, obtaining medication refills, and appointment-keeping in the treatment of cardiovascular disease. Prev Med 1999; 29: 535-548
28. Gagnayre R. Approche pédagogique de l'éducation du patient: méthodes et évaluations. Bulletin d'éducation du patient 1996; 15(3): 87-92
29. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance. A meta-analysis. Med Care 1998; 36(8): 1138-1161
30. Le point sur l'observance au cours des traitements antirétroviraux de l'infection à VIH. CRIPS Provence-Alpes-Côte d'Azur, mise à jour 1999
31. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med 2001; 134: 969-977
32. Duran S, Spire B, Raffi F, et al. Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clin Trials 2001; 2(1): 38-45
33. Ellis S, Shumaker S, Sieber W, et al. Adherence to pharmacological interventions: current trends and future directions. Control Clin Trials 2000; 21: 218S-225S
34. Le Bot M. Observance. Rev Prat 1999; 13(469): 1335-1348
35. Hyland ME. Types of noncompliance. Eur Respir Rev 1998; 8(56): 255-259
36. Shumaker SA, Dugan E, Bowen DJ. Enhancing adherence in randomized controlled trials. Control Clin Trials 2000; 21: 226S-232S